Home

Dysferlin-deficient muscular dystrophy and innate immune activation

Publication: 
FEBS J. 2013 Mar 25. doi: 10.1111/febs.12261. [Epub ahead of print]
Authors: 
Mariano A, Henning A, Han R.
Link: 
http://www.ncbi.nlm.nih.gov/pubmed/23527661

Long-term follow-up study on patients with Miyoshi phenotype of distal muscular dystrophy

Publication: 
Eur J Neurol. 2013 Mar 26. doi: 10.1111/ene.12129. [Epub ahead of print]
Authors: 
Linssen WH, de Voogt WG, Krahn M, Bernard R, Levy N, Wokke JH, Ginjaar HB, de Visser M.
Link: 
http://www.ncbi.nlm.nih.gov/pubmed/23530687

Dual Effects of Exercise in Dysferlinopathy

Publication: 
Am J Pathol. 2013 Apr 24. pii: S0002-9440(13)00252-6. doi: 10.1016/j.ajpath.2013.02.045. [Epub ahead of print]
Authors: 
Biondi O, Villemeur M, Marchand A, Chretien F, Bourg N, Gherardi RK, Richard I, Authier FJ.
Link: 
http://www.ncbi.nlm.nih.gov/pubmed/23624156

Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro

Publication: 
PLoS One. 2013 Apr 23;8(4):e61540. doi: 10.1371/journal.pone.0061540. Print 2013
Authors: 
Tanaka A, Woltjen K, Miyake K, Hotta A, Ikeya M, Yamamoto T, Nishino T, Shoji E, Sehara-Fujisawa A, Manabe Y, Fujii N, Hanaoka K, Era T, Yamashita S, Isobe K, Kimura E, Sakurai H.
Link: 
http://www.ncbi.nlm.nih.gov/pubmed/23626698

Assessment of disease activity in muscular dystrophies by noninvasive imaging

Publication: 
J Clin Invest 2013
Authors: 
Katie K. Maguire, Leland Lim, Sedona Speedy and Thomas A. Rando
Link: 
http://www.jci.org/articles/view/68458

Scientific Program

Description: 
Scientific Program for the 6th Dysferlin Conference
External Link: 
/2013-dysferlin-conference/scientific-program
Image: 
Image Type: 
Feature List
Module Options
Highlight Color: 
Default

Carla M Grosmann, MD

Grosmann, Carla

Associate Clinical Professor Neurosciences and Pediatrics
UCSD/Rady Children's Hospital San Diego

State: 
California
Country: 
United States

Attendees

Description: 
A list of all participants
External Link: 
/2013-dysferlin-conference/attendees
Image: 
Image Type: 
Feature List
Module Options
Highlight Color: 
Default

Confirmed Attendees

Description: 
A list of all confirmed participants
External Link: 
/2013-dysferlin-conference/confirmed-attendees
Image: 
Image Type: 
Feature List
Module Options
Highlight Color: 
Default
Link: 
FAQ: Diagnosis, Prognosis, Progression, and Inheritance

1α,25(OH)(2)-Vitamin D3 increases dysferlin expression in vitro and in a human clinical trial

Publication: 
Mol Ther. 2012 Oct;20(10):1988-97.
Authors: 
Luna ND, Díaz-Manera J, Paradas C, Iturriaga C, Rojas-García R, Araque J, Genebriera M, Gich I, Illa I, Gallardo E.
Link: 
http://www.ncbi.nlm.nih.gov/pubmed/22910291
Syndicate content